Gamida Cell

Allogeneic cell therapy approval to pave the way for future therapies in this class
Clinical Trials Arena
Mon, 05/1/23 - 10:05 am
Gamida Cell
stem cell transplant
Omisirge
blood cancer
FDA
How Gamida Cell’s FDA Approval Could Reduce Racial Disparities in Stem Cell Transplants
MedCity News
Mon, 04/17/23 - 10:54 pm
Gamida Cell
FDA
Omisirge
cell therapy
blood cancers
Gamida lays off 17%, ditches NK cell therapy work to keep blood cancer drug on track
Fierce Biotech
Mon, 03/27/23 - 09:55 am
Gamida Cell
layoffs
omidubicel
natural killer cells
FDA pushes back Gamida Cell’s PDUFA date by three months
Endpoints
Sun, 11/27/22 - 07:12 pm
Gamida Cell
PDUFA
FDA
omidubicel
FDA extends deadline to decide on Gamida Cell's stem cell transplant therapy by three months
Fierce Biotech
Tue, 11/22/22 - 04:27 pm
Gamida Cell
FDA
stem cells
stem cell transplant
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers
Businesswire
Thu, 09/29/22 - 09:59 am
Gamida Cell
solid tumors
blood cancers
omidubicel
Gamida doses first subject in Phase I/II cell therapy trial for lymphomas
Clinical Trials Arena
Thu, 08/11/22 - 12:17 pm
Gamida Cell
natural killer cell therapy
GDA-201
diffuse large B-cell lymphoma
follicular B-cell non-Hodgkin lymphoma
As sirens blare on biotech public markets, small cell therapy player Gamida plans to axe 10% of staff
Endpoints
Mon, 01/31/22 - 10:42 am
cell therapy
Gamida Cell
layoffs
Biotech companies raise cash as coronavirus updates lift stocks
BioPharma Dive
Tue, 05/19/20 - 11:24 pm
biotech
biotech stocks
COVID-19
Moderna Therapeutics
Bluebird Bio
Turning Point Therapeutics
Gossamer Bio
Krystal Biotech
Clovis Oncology
Gamida Cell
Bellerophon
Novartis-backed Gamida hits goal in phase 3 cancer trial
Fierce Biotech
Tue, 05/12/20 - 12:04 pm
Gamida Cell
Novartis
omidubicel
blood cancer
clinical trials
Gamida Cell raises $50M in NASDAQ IPO
BioCentury
Sat, 10/27/18 - 11:57 am
Gamida Cell
IPOs
NASDAQ
cell therapy
Novartis in constant evolution: new large investment in startup
GoinPharma
Sun, 10/21/18 - 11:31 pm
Gamida Cell
IPOs
Novartis
NiCord
Israel-Based Gamida Cell Files for $69 Million IPO
BioSpace
Mon, 10/1/18 - 07:21 pm
Gamida Cell
IPOs
Israel
NASDAQ
Gamida Cell launches severe aplastic anemia trial
Drug Delivery Business News
Tue, 08/22/17 - 12:01 am
Gamida Cell
severe aplastic anemia
CordIn
Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Endpoints
Tue, 06/20/17 - 09:20 am
Novartis
Gamida Cell
clinical trials
cell grafts
bone marrow
leukemia
lymphoma
Novartis-backed Gamida Cell grabs a breakthrough trophy for experimental cell treatment
Endpoints
Tue, 10/11/16 - 09:25 pm
Gamida Cell
Novartis
NiCord
bone marrow transplants
breakthrough status
Gamida Cell pockets $5M from Novartis ahead of mooted financing round
Fierce Biotech
Fri, 10/16/15 - 07:31 am
Gamida Cell
Novartis
Novartis pours another $15M into Israeli stem cell company
BioPharma Dive
Tue, 10/13/15 - 06:14 pm
Novartis
Israel
stem cells
Gamida Cell
Novartis makes concerted push into Israeli biotech startup scene
Fierce Biotech
Thu, 02/19/15 - 07:51 am
Novartis
Israel
Gamida Cell
BioLineRx
Novartis to invest in Israel's Gamida Cell, could buy out company
Yahoo/Reuters
Tue, 08/19/14 - 08:10 am
Israel
Novartis
stem cells
Gamida Cell
M&A

Pages